The thing is vivo, the need is still there, the trial
is more relevant than ever imo particularly with
the fda suggesting to target patients where efti
is likely to be of best benefit…
- Forums
- ASX - By Stock
- IMM
- Ann: New & significant data from AIPAC phase 2b trial in MBC
Ann: New & significant data from AIPAC phase 2b trial in MBC, page-18
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
40.0¢ | 41.0¢ | 39.5¢ | $1.515M | 3.783M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 115519 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 37481 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 115519 | 0.395 |
3 | 76000 | 0.390 |
4 | 68064 | 0.385 |
10 | 225656 | 0.380 |
1 | 8500 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 37481 | 2 |
0.410 | 240538 | 10 |
0.415 | 229395 | 10 |
0.420 | 502644 | 9 |
0.425 | 50700 | 3 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |